Percentage or count of CD19+ B lymphocytes in blood.
B-cell lymphoproliferative disorders
B-cell lymphoproliferative disorders are a group of conditions in which B cells, the white cells that make antibodies, grow in an abnormal, uncontrolled way. The group ranges from slow conditions that may never need treatment, such as monoclonal B-cell lymphocytosis, to chronic lymphocytic leukemia (CLL) and the many types of B-cell non-Hodgkin lymphoma. Some arise after an organ transplant or with a weakened immune system.
Lab tests linked to B-cell lymphoproliferative disorders:
- % CD19 (B cells): the share of lymphocytes that are B cells. It can be raised when abnormal B cells build up in the blood.
- Doctors also order a CBC with an absolute lymphocyte count, a blood smear, and flow cytometry to check whether the B cells come from a single clone. They may also order serum protein electrophoresis, LDH and beta-2 microglobulin. A lymph node or bone marrow biopsy is often needed for diagnosis.
How results are read:
- A raised B-cell percentage on its own is not a diagnosis. B cells can also rise for a while after infections and in some immune conditions.
- The key finding is clonality. Flow cytometry shows whether the B cells all carry the same light chain (kappa or lambda), which points to a lymphoproliferative disorder.
- A normal blood count does not rule out lymphoma, because many lymphomas stay in the lymph nodes.
When to see a doctor:
- See a doctor about lymph nodes that are growing or persist for more than a few weeks, drenching night sweats, unexplained fever or weight loss.
Clinical takeaway: a raised B-cell share is only a clue. Flow cytometry for a clonal B-cell population, and often a biopsy, make the diagnosis.
Biomarkers related to this condition
1 marker linked to this condition
Looking for a different marker? Browse all biomarkers →